Navigation Links
Abiant, Inc. Announces Close on Investment Round
Date:10/1/2007

CHICAGO, Oct. 1 /PRNewswire/ -- Abiant, Inc., an Illinois based company specializing advanced bio-imaging to accelerate and improve drug development and disease diagnosis, announces the successful closing of a $600,000 private placement. Lead investor Heartland Angels, an angel network specializing in early-stage technology, syndicated the round with Kettering Medical Center and other participants. Abiant has developed partnerships with large pharmaceutical companies and with academic collaborators. The company has obtained an exclusive license from New York University School of Medicine to image processing technology that has enabled the early and accurate identification of dementias.

Ed Maier, owner of the Maier Consulting Group and a former Senior Partner with Arthur Andersen, and Rick Mace, Vice President, Clinical Services Division of Kettering Medical Center, have joined Abiant's Board of Directors as part of this Offering. We are excited about supporting a technology that will change the way we monitor CNS drug effects in the clinical testing process", said Ron Kirschner, M.D., President of Heartland Angels. Dawn Matthews, President and CEO of Abiant, said "With this financing, we are adding two valuable strategic partners and the resources to expand the application of our imaging technology. We are eager to continue the progress created by the dedication and shared vision of our team, customers, and stakeholders." O.B. Parrish, Chairman of Abiant's Board, added "This financing provides Abiant with the opportunity to grow and capitalize on its technology".

About Abiant, Inc.

Abiant, Inc. uses proprietary image analysis methods and software to provide a sensitive biomarker of drug effects and disease progression. The imaging information, which includes biochemical, functional, and structural measurements, can be used to accelerate or reduce risk of decision making in both drug development and disease treatment. The Company's focus areas include the central nervous system, oncology, and inflammation. Further information can be found at http://www.abiant-imaging.com.

Forward Looking Statements

This press release may contain "forward-looking" statements identified by words such as "will," "continue," "grow," and "capitalize". There are a number of important factors that could cause Abiant's results to differ materially from those indicated by these forward-looking statements.


'/>"/>
SOURCE Abiant, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Conn. (PRWEB) , ... April 28, 2016 , ... ... financing and ongoing support for Connecticut's innovative, growing companies, today announced the launch ... health and financial technology (fintech) companies. , “VentureClash looks to attract ...
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the leading provider of ... that it has been named to The Silicon Review’s “20 Fastest Growing Big Data ... Cambridge Semantics serves the needs of end users facing some of the most complex ...
(Date:4/27/2016)... 2016 NanoStruck Technologies Inc. ... ( Frankfurt : 8NSK) gibt bekannt, ... 13. August 2015 die Genehmigung von der CNSX ... 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, um ... wurden 157.900.000 Einheiten mit dem ersten Teil der ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the use ... , PathSensors deploys the CANARY® test platform for the detection of harmful pathogens, ...
Breaking Biology Technology:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):